Other
2031
Medtronic 2031 increased by 0.1% to $1.27B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 7.1%, from $1.37B to $1.27B. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryProfitability
SignalLower is better
VolatilityStable
First reportedQ3 2016
Last reportedQ3 2026Feb 24, 2026
How to read this metric
Lower projected expenses in later years indicate the eventual expiration of amortization schedules for older acquisitions.
Detailed definition
This represents the projected amortization expense for finite-lived intangible assets for the year 2031. It is part of t...
Peer comparison
Standard disclosure for banks with significant historical acquisition activity.
Metric ID:
other_finite_lived_intangible_assets_amortization_expens_5777a7Historical Data
15 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.56B | $1.57B | $1.57B | $1.54B | $1.54B | $1.54B | $1.49B | $1.49B | $1.50B | $1.34B | $1.36B | $1.37B | $1.27B | $1.27B | $1.27B |
| QoQ Change | — | +0.7% | -0.1% | -1.8% | +0.0% | +0.2% | -3.4% | +0.3% | +0.3% | -10.3% | +0.9% | +0.7% | -7.2% | +0.0% | +0.1% |
| YoY Change | — | — | — | -1.2% | -1.9% | -1.7% | -3.2% | -3.0% | -2.9% | -9.7% | -9.2% | -8.9% | -5.7% | -6.6% | -7.1% |
Range$1.27B – $1.57B
CAGR-5.7%
Avg YoY Growth-5.1%
Median YoY Growth-4.5%
Current Streak2 quarters growth
2031 at Other Companies
Frequently Asked Questions
- What is Medtronic's 2031?
- Medtronic (MDT) reported 2031 of $1.27B in Q4 2025.
- How has Medtronic's 2031 changed year-over-year?
- Medtronic's 2031 decreased by 7.1% year-over-year, from $1.37B to $1.27B.
- What does 2031 mean?
- The expected non-cash expense for acquired intangible assets in the year 2031.